Brokerage: Macquarie | Rating: Upgrade to Outperform | Target: Raised to Rs 322
The brokerage house increased FY20 EBITDA estimates By 11%.
Brokerage: Macquarie | Rating: Outperform | Target: Raised to Rs 1,860
The brokerage house said that the firm is set for continued earnings upgrades.
Brokerage: Morgan Stanley | Rating: overweight | Target: Raised to Rs 1,650
Morgan Stanley said that the firm is the best proxy for coming construction boom in India.
Brokerage: CLSA | Rating: Buy | Target: Raised to Rs 1,680
The brokerage said that the firm ticked all the right boxes in Q3. It is a good proxy for domestic capex and added that the company has a credible strategy to improve growth and RoE.
Brokerage: Deutsche Bank | Rating: Buy | Target: Raised to Rs 380
The global research firm said that there was no divergence, revenue drivers were weak.
Further, it said that net interest margins and free income were weak, while loan growh picks up.
Brokerage: Morgan Stanley | Rating: Overweight | Target: Rs 480
The brokerage house said that the asset quality continued the path of normalization, while the company remains a top pick for the firm.
Brokerage: Nomura | Rating: Buy | Target: Rs 375
The global research firm said that an improvement in core PPoP to assets key to re-rating.
Brokerage: Macquarie | Rating: Outperform | Target: Raised to Rs 425
The brokerage believes that no divergence is material positive.
Brokerage: CLSA | Rating: Buy | Target: Rs 422
CLSA said that Q3 EBITDA was in-line with estimates but net profit misses. Further, it cut FY18 EPS by 6 percent, factoring in Q3 profit miss. It sees a strong 37 percent EPS CAGR over the next two years.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
